Related Experiment Video

Updated: Aug 9, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Reverse remodelling in heart failure with cardiac resynchronisation therapy

M St John Sutton1, M G Keane

  • 1Division of Cardiology, Department of Medicine, University of Pennsylvania Medical Center, Room 9017, Gates Pavilion, 3400, Spruce Street, Philadelphia, PA 19104, USA. suttonm@mail.med.upenn.edu

Heart (British Cardiac Society)
|April 29, 2006
PubMed

Insights

Cardiac resynchronisation therapy (CRT) effectively treats severe systolic heart failure by reversing adverse left ventricular (LV) remodelling. This innovative treatment improves heart function and prognosis in patients with chronic heart failure.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Medical Device Technology

Background:

  • Systolic heart failure is characterized by progressive left ventricular (LV) remodelling, leading to poor prognosis.
  • LV remodelling involves dilatation, reduced contractile function, and altered cavity shape, triggered by various factors.
  • Current treatments focus on slowing or halting this detrimental remodelling process.

Purpose of the Study:

  • To review the application of cardiac resynchronisation therapy (CRT) in managing chronic, severe, systolic heart failure.
  • To explore the concept of "reverse remodelling" as a therapeutic goal in heart failure.
  • To evaluate CRT's efficacy in achieving reverse remodelling and improving LV function.

Main Methods:

  • Review of existing literature on cardiac resynchronisation therapy and heart failure.
  • Analysis of studies investigating left ventricular remodelling in systolic heart failure.
  • Examination of data correlating CRT with changes in LV structure and function.

Main Results:

  • Cardiac resynchronisation therapy (CRT) is identified as a novel and effective treatment for systolic heart failure.
  • CRT is associated with significant "reverse remodelling" of the left ventricle.
  • This reverse remodelling involves partial reversal of LV dilatation and improved contractile function.

Conclusions:

  • Cardiac resynchronisation therapy (CRT) offers a promising therapeutic approach for severe systolic heart failure.
  • CRT facilitates reverse remodelling, counteracting the adverse effects of LV remodelling.
  • The findings support CRT as a valuable intervention for improving outcomes in heart failure patients.

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...